A carregar...

In Vitro Anti-Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657

The new rifamycin derivatives KRM-1657 and KRM-1648 were evaluated for their in vitro antimicrobial activities against 44 strains of Helicobacter pylori. Although the drugs were not very active against other gram-negative bacteria, the MICs at which 90% of isolates are inhibited for these drugs were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Akada, Junko K., Shirai, Mutsunori, Fujii, Kenji, Okita, Kiwamu, Nakazawa, Teruko
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1999
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC89113/
https://ncbi.nlm.nih.gov/pubmed/10223916
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!